WO2008120744A1 - 5員環アミド化合物およびその用途 - Google Patents
5員環アミド化合物およびその用途 Download PDFInfo
- Publication number
- WO2008120744A1 WO2008120744A1 PCT/JP2008/056173 JP2008056173W WO2008120744A1 WO 2008120744 A1 WO2008120744 A1 WO 2008120744A1 JP 2008056173 W JP2008056173 W JP 2008056173W WO 2008120744 A1 WO2008120744 A1 WO 2008120744A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- amide compound
- membered cyclic
- cyclic amide
- compound
- disclosed
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Diabetes (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Child & Adolescent Psychology (AREA)
- Gastroenterology & Hepatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
優れたSCD1活性阻害作用を有する化合物を提供すること。下記一般式[A-1’]で表される化合物又はその医薬上許容される塩、或いはその溶媒和物:
[式中、各記号は明細書中で定義した通りである。]。
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2007095470 | 2007-03-30 | ||
JP2007-095470 | 2007-03-30 | ||
US92580307P | 2007-04-23 | 2007-04-23 | |
US60/925,803 | 2007-04-23 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2008120744A1 true WO2008120744A1 (ja) | 2008-10-09 |
Family
ID=39808324
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2008/056173 WO2008120744A1 (ja) | 2007-03-30 | 2008-03-28 | 5員環アミド化合物およびその用途 |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2008120744A1 (ja) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2009106203A1 (en) * | 2008-02-25 | 2009-09-03 | Merck Patent Gmbh | Glucokinase activators |
WO2013056148A2 (en) | 2011-10-15 | 2013-04-18 | Genentech, Inc. | Methods of using scd1 antagonists |
US10973810B2 (en) | 2017-01-06 | 2021-04-13 | Yumanity Therapeutics, Inc. | Methods for the treatment of neurological disorders |
US11873298B2 (en) | 2017-10-24 | 2024-01-16 | Janssen Pharmaceutica Nv | Compounds and uses thereof |
US11970486B2 (en) | 2016-10-24 | 2024-04-30 | Janssen Pharmaceutica Nv | Compounds and uses thereof |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0324066A (ja) * | 1989-06-14 | 1991-02-01 | Bayer Ag | 2‐アシルアミノ‐4‐ハロゲノ‐5‐ニトロチアゾール誘導体、その製造方法、殺有害生物剤としてのその利用、および新規中間体 |
WO2007022258A1 (en) * | 2005-08-17 | 2007-02-22 | Schering Corporation | Novel high affinity thiophene-based and furan-based kinase ligands |
WO2008044767A1 (fr) * | 2006-10-13 | 2008-04-17 | Takeda Pharmaceutical Company Limited | Dérivé d'amine aromatique et utilisation de celui-ci |
-
2008
- 2008-03-28 WO PCT/JP2008/056173 patent/WO2008120744A1/ja active Application Filing
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0324066A (ja) * | 1989-06-14 | 1991-02-01 | Bayer Ag | 2‐アシルアミノ‐4‐ハロゲノ‐5‐ニトロチアゾール誘導体、その製造方法、殺有害生物剤としてのその利用、および新規中間体 |
WO2007022258A1 (en) * | 2005-08-17 | 2007-02-22 | Schering Corporation | Novel high affinity thiophene-based and furan-based kinase ligands |
WO2008044767A1 (fr) * | 2006-10-13 | 2008-04-17 | Takeda Pharmaceutical Company Limited | Dérivé d'amine aromatique et utilisation de celui-ci |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2009106203A1 (en) * | 2008-02-25 | 2009-09-03 | Merck Patent Gmbh | Glucokinase activators |
JP2014208665A (ja) * | 2008-02-25 | 2014-11-06 | メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツングMerck Patent Gesellschaft mit beschraenkter Haftung | グルコキナーゼ活性化剤 |
WO2013056148A2 (en) | 2011-10-15 | 2013-04-18 | Genentech, Inc. | Methods of using scd1 antagonists |
US9358250B2 (en) | 2011-10-15 | 2016-06-07 | Genentech, Inc. | Methods of using SCD1 antagonists |
US11970486B2 (en) | 2016-10-24 | 2024-04-30 | Janssen Pharmaceutica Nv | Compounds and uses thereof |
US10973810B2 (en) | 2017-01-06 | 2021-04-13 | Yumanity Therapeutics, Inc. | Methods for the treatment of neurological disorders |
US11873298B2 (en) | 2017-10-24 | 2024-01-16 | Janssen Pharmaceutica Nv | Compounds and uses thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2008120759A1 (ja) | ウレア化合物およびその用途 | |
WO2008123469A1 (ja) | 6員環アミド化合物およびその用途 | |
TW200732336A (en) | Alyphactic heterocyclic compounds | |
WO2009048101A1 (ja) | アミド化合物 | |
WO2009051244A1 (ja) | 複素環化合物 | |
WO2007135527A3 (en) | Benzimidazolyl compounds | |
MY146923A (en) | Novel piperazine compound, and use thereof as hcv polymerase inhibitor | |
EP1864665A4 (en) | IMMUNOSUPPRESSIVE AGENT AND ANTI-TUMOR AGENT COMPRISING A HETEROCYCLIC COMPOUND AS ACTIVE INGREDIENT | |
WO2008011130A8 (en) | Amide compounds | |
WO2009154300A3 (en) | Heterocyclic compound and use thereof | |
WO2009060835A1 (ja) | 新規ユビキリン結合性小分子 | |
WO2008075068A3 (en) | Acylaminopyrazoles as fgfr inhibitors | |
WO2008011131A3 (en) | Amide compounds | |
WO2007136592A3 (en) | 2-0x0-l,2-dihydr0quin0line derivatives, compositions, and uses thereof as antiproliferative agents | |
WO2006105888A3 (de) | Synergistische fungizide wirkstoffkombinationen | |
WO2009026166A3 (en) | Antiinfective flavonol compounds and methods of use thereof | |
TW200716541A (en) | The preparation and use of compounds as protease inhibitors | |
WO2008057871A3 (en) | Inhibitors of hepatitis c virus | |
WO2008153159A1 (ja) | アミン化合物及びその医薬用途 | |
EP2639229A3 (en) | Thiazole Derivative and use thereof as VAP-1 Inhibitor | |
WO2008105526A1 (ja) | マクロ環状化合物 | |
WO2007017728A3 (en) | Novel heterocyclic compounds | |
WO2006041631A3 (en) | Novel cyclosporin alkynes and their utility as pharmaceutical agents | |
WO2009041663A1 (ja) | 皮膚疾患の予防及び/または治療剤 | |
WO2008114812A1 (ja) | Jak阻害剤 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 08739291 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 08739291 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: JP |